Kamala Harris unveils drug pricing plan: 5 notes 

Kamala Harris, senator of California and Democratic presidential hopeful, released a plan July 16 to lower prescription drug prices. 

Five quick takeaways:

  1. Ms. Harris' plan would authorize HHS to annually set fair prices for drugs based on average prices of those drugs in comparable countries like Canada, France, Germany and Japan. 
  2. Ms. Harris' plan would tax pharmaceutical company profits from selling drugs at a cost more than 100 percent above the fair price benchmark. The proceeds would be returned to consumers through rebates. 
  3. HHS would also intervene if drug companies raise the prices faster than inflation.
  4. Her plan would also close a loophole in the tax code related to direct-to-consumer advertising for drug companies. The proceeds would be used as funding for NIH drug research. 
  5. The federal government would take regulatory action against companies that fail to comply with fair pricing, including licensing patents to competitor companies if necessary. 

More articles on leadership and management:

Cleveland Clinic Euclid Hospital's Dr. Teresa Dews on driving growth and loving your work
Biden, Sanders welcome fight on healthcare: 4 notes on the Democrats' growing division
Cory Booker's long-term care plan

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars